Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Bacterial Content of Fortified and Unfortified Holder Pasteurized Donor Human Milk during Prolonged Refrigerated Storage.

Mandru C, Perrin MT, Iyer R, Liveris D, Schwartz I, Alpan G, Parvez B.

J Pediatr Gastroenterol Nutr. 2019 Jun 20. doi: 10.1097/MPG.0000000000002427. [Epub ahead of print]

PMID:
31232828
2.

Two Distinct Mechanisms Govern RpoS-Mediated Repression of Tick-Phase Genes during Mammalian Host Adaptation by Borrelia burgdorferi, the Lyme Disease Spirochete.

Grove AP, Liveris D, Iyer R, Petzke M, Rudman J, Caimano MJ, Radolf JD, Schwartz I.

MBio. 2017 Aug 22;8(4). pii: e01204-17. doi: 10.1128/mBio.01204-17.

3.

Therapeutic Restoration of Endothelial Glycocalyx in Sepsis.

Song JW, Zullo JA, Liveris D, Dragovich M, Zhang XF, Goligorsky MS.

J Pharmacol Exp Ther. 2017 Apr;361(1):115-121. doi: 10.1124/jpet.116.239509. Epub 2017 Feb 6.

4.

Molecular Typing of Borrelia burgdorferi.

Wang G, Liveris D, Mukherjee P, Jungnick S, Margos G, Schwartz I.

Curr Protoc Microbiol. 2014 Aug 1;34:12C.5.1-31. doi: 10.1002/9780471729259.mc12c05s34.

5.

Induction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36.

Krupna-Gaylord MA, Liveris D, Love AC, Wormser GP, Schwartz I, Petzke MM.

PLoS One. 2014 Jun 19;9(6):e100174. doi: 10.1371/journal.pone.0100174. eCollection 2014.

6.

Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.

Wormser GP, Aguero-Rosenfeld ME, Cox ME, Nowakowski J, Nadelman RB, Holmgren D, McKenna D, Bittker S, Zentmaier L, Cooper D, Liveris D, Schwartz I, Horowitz HW.

J Clin Microbiol. 2013 Mar;51(3):954-8. doi: 10.1128/JCM.02929-12. Epub 2013 Jan 9.

7.

Differentiation of reinfection from relapse in recurrent Lyme disease.

Nadelman RB, Hanincová K, Mukherjee P, Liveris D, Nowakowski J, McKenna D, Brisson D, Cooper D, Bittker S, Madison G, Holmgren D, Schwartz I, Wormser GP.

N Engl J Med. 2012 Nov 15;367(20):1883-90. doi: 10.1056/NEJMoa1114362.

8.

Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease.

Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman R, Demarco J, Iyer R, Bittker S, Cooper D, Holmgren D, Wormser GP.

Diagn Microbiol Infect Dis. 2012 Jul;73(3):243-5. doi: 10.1016/j.diagmicrobio.2012.03.026. Epub 2012 May 8.

9.

Quantitation of cell-associated borrelial DNA in the blood of Lyme disease patients with erythema migrans.

Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman RB, DeMarco J, Iyer R, Cox ME, Holmgren D, Wormser GP.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):791-5. doi: 10.1007/s10096-011-1376-x. Epub 2011 Aug 16.

PMID:
21842448
10.

Improving the yield of blood cultures from patients with early Lyme disease.

Liveris D, Schwartz I, Bittker S, Cooper D, Iyer R, Cox ME, Wormser GP.

J Clin Microbiol. 2011 Jun;49(6):2166-8. doi: 10.1128/JCM.00350-11. Epub 2011 Apr 13.

11.

Borrelia burgdorferi bba74 is expressed exclusively during tick feeding and is regulated by both arthropod- and mammalian host-specific signals.

Mulay VB, Caimano MJ, Iyer R, Dunham-Ems S, Liveris D, Petzke MM, Schwartz I, Radolf JD.

J Bacteriol. 2009 Apr;191(8):2783-94. doi: 10.1128/JB.01802-08. Epub 2009 Feb 13.

12.

A single mutation in the IF3 N-terminal domain perturbs the fidelity of translation initiation at three levels.

Maar D, Liveris D, Sussman JK, Ringquist S, Moll I, Heredia N, Kil A, Bläsi U, Schwartz I, Simons RW.

J Mol Biol. 2008 Nov 28;383(5):937-44. doi: 10.1016/j.jmb.2008.09.012. Epub 2008 Sep 16.

PMID:
18805426
13.

Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.

Wormser GP, Brisson D, Liveris D, Hanincová K, Sandigursky S, Nowakowski J, Nadelman RB, Ludin S, Schwartz I.

J Infect Dis. 2008 Nov 1;198(9):1358-64. doi: 10.1086/592279.

14.

Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease.

Wormser GP, Liveris D, Hanincová K, Brisson D, Ludin S, Stracuzzi VJ, Embers ME, Philipp MT, Levin A, Aguero-Rosenfeld M, Schwartz I.

Clin Infect Dis. 2008 Oct 1;47(7):910-4. doi: 10.1086/591529.

15.

Borrelia burgdorferi vlsE antigenic variation is not mediated by RecA.

Liveris D, Mulay V, Sandigursky S, Schwartz I.

Infect Immun. 2008 Sep;76(9):4009-18. doi: 10.1128/IAI.00027-08. Epub 2008 Jul 7.

16.

Borrelia burgdorferi sensu stricto is clonal in patients with early Lyme borreliosis.

Hanincová K, Liveris D, Sandigursky S, Wormser GP, Schwartz I.

Appl Environ Microbiol. 2008 Aug;74(16):5008-14. doi: 10.1128/AEM.00479-08. Epub 2008 Jun 6.

17.

Borrelia burgdorferi BBA74, a periplasmic protein associated with the outer membrane, lacks porin-like properties.

Mulay V, Caimano MJ, Liveris D, Desrosiers DC, Radolf JD, Schwartz I.

J Bacteriol. 2007 Mar;189(5):2063-8. Epub 2006 Dec 22.

18.

Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis.

Wormser GP, Filozov A, Telford SR 3rd, Utpat S, Kamer RS, Liveris D, Wang G, Zentmaier L, Schwartz I, Aguero-Rosenfeld ME.

Vector Borne Zoonotic Dis. 2006 Winter;6(4):388-94.

PMID:
17187574
19.

Association between human leukocyte antigen class II alleles and genotype of Borrelia burgdorferi in patients with early lyme disease.

Wormser GP, Kaslow R, Tang J, Wade K, Liveris D, Schwartz I, Klempner M.

J Infect Dis. 2005 Dec 1;192(11):2020-6. Epub 2005 Oct 28.

20.
21.

A skin lesion in a patient from Kentucky.

Haddad FA, Schwartz I, Liveris D, Wormser GP.

Clin Infect Dis. 2005 Feb 1;40(3):429, 475-6. No abstract available.

PMID:
15685719
22.

Microbiologic evaluation of patients from Missouri with erythema migrans.

Wormser GP, Masters E, Liveris D, Nowakowski J, Nadelman RB, Holmgren D, Bittker S, Cooper D, Wang G, Schwartz I.

Clin Infect Dis. 2005 Feb 1;40(3):423-8. Epub 2005 Jan 10.

23.

In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis.

Bayard-Mc Neeley M, Bansal A, Chowdhury I, Girao G, Small CB, Seiter K, Nelson J, Liveris D, Schwartz I, Mc Neeley DF, Wormser GP, Aguero-Rosenfeld ME.

J Clin Pathol. 2004 May;57(5):499-503.

24.

Functional properties of Borrelia burgdorferi recA.

Liveris D, Mulay V, Schwartz I.

J Bacteriol. 2004 Apr;186(8):2275-80.

25.
26.

Avian reservoirs of the agent of human granulocytic ehrlichiosis?

Daniels TJ, Battaly GR, Liveris D, Falco RC, Schwartz I.

Emerg Infect Dis. 2002 Dec;8(12):1524-5. No abstract available.

27.

Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain.

Wang G, Ojaimi C, Wu H, Saksenberg V, Iyer R, Liveris D, McClain SA, Wormser GP, Schwartz I.

J Infect Dis. 2002 Sep 15;186(6):782-91. Epub 2002 Aug 20.

28.

Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings.

Liveris D, Wang G, Girao G, Byrne DW, Nowakowski J, McKenna D, Nadelman R, Wormser GP, Schwartz I.

J Clin Microbiol. 2002 Apr;40(4):1249-53.

29.

Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques.

Nowakowski J, Schwartz I, Liveris D, Wang G, Aguero-Rosenfeld ME, Girao G, McKenna D, Nadelman RB, Cavaliere LF, Wormser GP; Lyme Disease Study Group.

Clin Infect Dis. 2001 Dec 15;33(12):2023-7. Epub 2001 Nov 7.

PMID:
11700579
30.

Characterization of Borrelia burgdorferi isolated from erythema migrans lesions: interrelationship of three molecular typing methods.

Iyer R, Liveris D, Adams A, Nowakowski J, McKenna D, Bittker S, Cooper D, Wormser GP, Schwartz I.

J Clin Microbiol. 2001 Aug;39(8):2954-7.

31.

Borrelia lonestari infection after a bite by an Amblyomma americanum tick.

James AM, Liveris D, Wormser GP, Schwartz I, Montecalvo MA, Johnson BJ.

J Infect Dis. 2001 Jun 15;183(12):1810-4. Epub 2001 May 17.

PMID:
11372036
32.

Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease.

Wormser GP, Liveris D, Nowakowski J, Nadelman RB, Cavaliere LF, McKenna D, Holmgren D, Schwartz I.

J Infect Dis. 1999 Sep;180(3):720-5.

PMID:
10438360
33.

Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens.

Liveris D, Varde S, Iyer R, Koenig S, Bittker S, Cooper D, McKenna D, Nowakowski J, Nadelman RB, Wormser GP, Schwartz I.

J Clin Microbiol. 1999 Mar;37(3):565-9.

34.

Perinatal transmission of the agent of human granulocytic ehrlichiosis.

Horowitz HW, Kilchevsky E, Haber S, Aguero-Rosenfeld M, Kranwinkel R, James EK, Wong SJ, Chu F, Liveris D, Schwartz I.

N Engl J Med. 1998 Aug 6;339(6):375-8. No abstract available.

35.

Culture-confirmed infection and reinfection with Borrelia burgdorferi.

Nowakowski J, Schwartz I, Nadelman RB, Liveris D, Aguero-Rosenfeld M, Wormser GP.

Ann Intern Med. 1997 Jul 15;127(2):130-2. No abstract available.

PMID:
9230002
36.

Lyme disease and ehrlichiosis.

Liveris D.

Clin Podiatr Med Surg. 1996 Oct;13(4):595-634. Review.

PMID:
8902334
37.

Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis.

Liveris D, Wormser GP, Nowakowski J, Nadelman R, Bittker S, Cooper D, Varde S, Moy FH, Forseter G, Pavia CS, Schwartz I.

J Clin Microbiol. 1996 May;34(5):1306-9.

39.

rRNA operon multiplicity in Escherichia coli and the physiological implications of rrn inactivation.

Condon C, Liveris D, Squires C, Schwartz I, Squires CL.

J Bacteriol. 1995 Jul;177(14):4152-6.

40.
41.

Sequence analysis of the ribosomal RNA operon of the Lyme disease spirochete, Borrelia burgdorferi.

Gazumyan A, Schwartz JJ, Liveris D, Schwartz I.

Gene. 1994 Aug 19;146(1):57-65.

PMID:
7520403
42.

Molecular cloning and sequencing of infC, the gene encoding translation initiation factor IF3, from four enterobacterial species.

Liveris D, Schwartz JJ, Geertman R, Schwartz I.

FEMS Microbiol Lett. 1993 Sep 1;112(2):211-6.

PMID:
8405963
43.

Structure-function analysis of Escherichia coli translation initiation factor IF3: tyrosine 107 and lysine 110 are required for ribosome binding.

De Bellis D, Liveris D, Goss D, Ringquist S, Schwartz I.

Biochemistry. 1992 Dec 8;31(48):11984-90.

PMID:
1457399
44.

Growth rate regulation of translation initiation factor IF3 biosynthesis in Escherichia coli.

Liveris D, Klotsky RA, Schwartz I.

J Bacteriol. 1991 Jun;173(12):3888-93.

Supplemental Content

Loading ...
Support Center